CHU Saint-Etienne
Saint-Etienne, 42055, France
NCT Number: NCT02595112
Staphylococcus aureus nasal carriage is a major risk factor of infection with this bacterium. Staphylococcus aureus colonization of the posterior nasal cavity is still misunderstood. This study is aimed at evaluating the relationship between Staphylococcus aureus strains colonizing the vestibulum nasi, the sphenoethmoidal recess and the nasopharynx.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Saint-Etienne, 42055, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vestibulum nasi and posterior nasal cavity sampling with swabs and posterior nasal cavity sampling by endoscopic procedure during otorhinolaryngologic surgery
Time frame: Day 1
Time frame: Day 1
Centre Hospitalier Universitaire de Saint Etienne
Other
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery. A Monocentric Study
Acronym: SREENSTAPH2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07013864
Bacterial Infections, Bacterial Infections and Mycoses
Saint-Denis, France
View Trial DetailsNCT00501150
Bacterial Infections, Bacterial Infections and Mycoses
London, United Kingdom
View Trial DetailsNCT03915470
Bacterial Infections, Bacterial Infections and Mycoses
Gainesville, Florida, United States
View Trial DetailsNCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial Details